The Pulse – Newsletter for Leaders in the Medical Device Industry – April 2007
April 10, 2007
The rapidly changing legislative, reimbursement, regulatory, and technology landscapes, coupled with increasing civil and criminal liability, have posed significant challenges and offered tremendous opportunities for medical device manufacturers.
To help you address these developments, the Medical Device attorneys of Foley & Lardner LLP provide fully integrated experience in U.S. Food and Drug Administration (FDA) and health care regulatory issues, reimbursement, intellectual property law (IP), business law, litigation, and public affairs, enabling us to collaboratively craft effective strategies and implement them with clients.
Read The Pulse newsletter by clicking on the link below.
Author(s)
Related Insights
July 11, 2025
Foley Viewpoints
Department of Justice Launches Program to Reward Antitrust Whistleblowers with Shares of Criminal Fines
On July 8, 2025, the U.S. Department of Justice, Antitrust Division (“Antitrust Division”) announced a new “Whistleblower Rewards…
July 23, 2025
Events
Healthcare Supply Chain Compliance Challenges: Vendor Management, Contract Negotiation, Tariff Impact
Foley partner Monica Chmielewski, vice chair of the firm’s Health Care Practice Group, is speaking in Strafford’s upcoming webinar titled “Healthcare Supply Chain Compliance Challenges: Vendor Management, Contract Negotiation, Tariff Impact” on July 23.
September 30, 2025
Events
FDA Regulation of AI-Enabled Medical Devices
Foley partner Kyle Faget, co-chair of the firm’s Medical Devices Area of Focus, is speaking at the American Bar Association Health Law Section’s Healthcare Delivery & Innovation Conference on September 30.